Moreover, while CLL cells showed an enhanced, similar migratory response to both CCR7 ligands, normal B-cells showed a moderate response, and preferentially towards CCL21 (13, 35, 40, 46). The gene discussed is CCR7; the disease is B-cell chronic lymphocytic leukemia.